When ingestion was normalized to GFAP burden, there was still a significant effect of cohort (p < 0.0001) with both AD and aged controls having more synapse colocalization with astrocytes than midlife controls in post hoc tests (Figure S1D). Here, GFAP is linked to Alzheimer disease.